Article Figures & Data
Figures
- Figure 1
Meta-analysis of genotype-guided strategy in patients with acute coronary syndrome or undergoing percutaneous coronary intervention. IAC-PCI: Individual Applications of Clopidogrel After Percutaneous Coronary Intervention (ChiCTR-TRC-11001807); Tam et al (2017) (NCT01994941); ONSIDE TEST: Optimal Antiplatelet Pharmacotherapy Guided by Bedside Genetic or Functional Testing in Elective Percutaneous Coronary Intervention (NCT01930773); PHARMCLO: Pharmacogenetics of Clopidogrel in Patients With Acute Coronary Syndromes (NCT03347435); POPular Genetics: CYP2C19 Genotype Guided Antiplatelet Therapy in ST-Segment Elevation Myocardial Infarction Patients-Patient Outcome After Primary PCI (NCT01761786); TAILOR-PCI: Tailored Antiplatelet Therapy Following PCI (NCT01742117).
